5,358,857 A 10/1994 Stengelin et al. 5,470,570 A 11/1995 Taylor et al. 5.487, 890 A 1/1996
Taylor et al. 5,879,679 A 3/1999 Taylor et al. 5,885,808 A 3/1999 Spooner et al. 5,886,143 A …

(63) Related US Application Data Continuation of application No. 14/460,768, filed on Aug.
15, 2014, now Pat. No. 9,850,296, which is a continuation of application No …

(63) Continuation of application No. PCT/IB2013/000684, filed on Feb. 15, 2013, and a
continuation-in-part of application No. 13/397, 202, filed on Feb. 15, 2012, now Pat. No. 9 …

Peptides that specifically bind erythrocytes are described. These are provided as peptidic
ligands having sequences that specifically bind, or as antibodies or fragments thereof that …

US20170327800A1 - Methods and compositions for treating ineffective erythropoiesis -
Google Patents US20170327800A1 - Methods and compositions for treating ineffective …

US20150266950A1 - Methods for treating anemia - Google Patents US20150266950A1 -
Methods for treating anemia - Google Patents Methods for treating anemia Download PDF …

US PATENT DOCUMENTS 4,916,071 A 4/1990 Hung et al. 5,229,367 A 7, 1993 Perretti et
al. 5,480,869 A 1/1996 Wei et al. 5,653,979 A 8/1997 Muzykantov et al. 6,488,927 B2 …

Peptides that specifically bind erythrocytes are described. These are provided as peptidic
ligands having sequences that specifically bind, or as antibodies or fragments thereof that …

Peptides that specifically bind erythrocytes are described. These are provided as peptidic
ligands having sequences that specifically bind, or as antibodies or fragments thereof that …

Peptides that specifically bind erythrocytes are described. These are provided as peptidic
ligands having sequences that specifically bind, or as antibodies or fragments thereof that …